One beneficiary was Hilaria Swisher. She has struggled with her weight since she was little, butGLP-1 drugshave recently helped her. "That's not me," she said, of an old photo of herself. "I look at that person and who I am now and I don't see me there. And even when this pi...
The FDA’s Closer to Zero initiative—meant to reduce dietary exposure to contaminants while maintaining access to nutritious food—is, at its core, designed to protect vulnerable populations such as children and pregnant women. Specifically, the focus has been on arsenic, lead, cadmium, and mer...
Recently, they’ve been heralded in the media for their efficacy, convenience and safety, but, in fact, GLP-1 drugs are nothing new. The US FDA approved first-generation GLP-1 meds to treat diabetes as far back as 2005. Prior to its role in countering obesity, Ozempic, was approved ...
Glucagon-Like Peptide -1 or GLP-1 drugs, originally developed for treatment of diabetes, have recently grabbed the headlines as users have reported immediate and often effortless weight loss results. A survey conducted in concert with the Citi innovation lab analyzed 1,000 U.S. adults, 499 of ...
Recently, Dongbao Zixing (Hangzhou) Biopharmaceutical Co., Ltd. ("Dongbao Zixing"), a wholly owned subsidiary of Tonghua Dongbao Pharmaceutical Co., Ltd. (the "Company" or "Tonghua Dongbao") received a notice of acceptance (No. CXHL2300887) from the Center for Drug Evaluation of the National...
Jennifer is a NASM-Certified Nutrition Coach and freelance writer, passionate about educating others in all aspects of nutrition, fitness, and self-care. Over the years, she has worked closely with a number of CPG health and wellness brands and publications, including LIVESTRONG.com, Healthnews,...
Recently, a study in Nature Medicine evaluated the risk of suicidal thoughts in patients taking GLP-1 drugs. While that study revealed that there is no correlation between suicidal ideation and GLP-1 use, theFDA continues to investigate the safety of these drugs. ...
The global obesity epidemic is growing and the competition to develop effective and convenient weight loss treatments is heating up. Recently injectable GLP-1 receptor agonists like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound have been the stars of the show, delivering impressive weight loss ...
While during the COVID-19 pandemic Americans gravitated toward comfortable, baggy and sometimes figure-hiding clothing like sweatpants, O'Donnell of market-research company Kantar said that, anecdotally, she's recently seen a rise in consumers gravitating toward stretchy, body-hugging fabrics, as well...
Separately, efinopegdutide was recently granted Fast Track Designation from the U.S. Food and Drug Administration (FDA) as a potential treatment for patients with nonalcoholic steatohepatitis (NASH), a more...